+34 620 10 75 37info@nanbiosis.com

Posts Taged jumisc

You are here : Home / Posts Tagged "JUMISC"

NANBIOSIS keeps working in SAFE-N-MEDTECH!

On March 10-12 a two-day meeting between representatives of NANBIOSIS units, took place at the  Jesús Usón Minimum Invasive Surgery Center (CCMIJU), in Cáceres, to plan the work to be done in the coming months and carry out some tests within the framework of the European project Safe-N-MedTech.

Several units of the ICTS NANBIOSIS will carry out some of the F/Q, in vivo and in vitro characterizations applied to the test cases of the project. NANBIOSIS is actively involved and works in close collaboration with the four Test Case Developers: Stryker, RCL, HELIA Biomonitoring and TECNAN. Additionally, NANBIOSIS is the leader of WP3 Preclinical Research in nano enabled MTs.

The Safe-N-MedTech European Project will create an open innovation platform that accelerates the development of medical devices based on nanotechnologies. The project counts with 28 partners coordinated by TECNAN (Navarre, Spain), together with BIOKERALTY, the research branch of the global health companies Keralty. The new project is part of the Open Innovation Test Bed initiative (OITB) launched by the European Commission with the aim of accelerating the development of medical devices based on nanotechnologies in Europe and abroad. The project has a European funding of 15 million euros.

We expect that the Safe-N-MedTech test bed will help to accelerate the development nanotechnology based medical technologies products and services for future applications in clinical practice.

Safe-N-Medtech kicks off in Bilbao
• Read More

The European Union highlights the relevance of the JUMISC’s Cutting-Edge Infraestructures and Technology, recognized as ICTS.

Jesús Usón Minimally Invasive Surgery Center (JUMISC), from Cáceres, partnert of NANBIOSIS, has recently made headlines on the website of the European Commission as an innovative center for Biomedical and Health Research.

In the interview to his Director, Francisco Miguel Sanchez Margallo, he explained how European Funds allowed Infraestructures and Vanguard Technology for biomedical research at the CCMIJU, which have already been recognized, as part of NANBIOSIS, with CIBER-BBN and BIONAND, as “Singular Scientific and Technical Infrastructure” (ICTS).

Complete news at European Commision’s Website: https://ec.europa.eu/spain/news/investeu_caceres_es

https://ec.europa.eu/spain/news/investeu_caceres_es
• Read More

Mimicking physiological O2 tension in the female reproductive tract improves assisted reproduction outcomes in pig

Francisco M. Sánchez-Margallo, Assistant Director of NANBIOSIS and Scientific Coordinator o NANBIOSIS U23. Assisted Reproduction,  is co-author of the article “Mimicking physiological O2 tension in the female reproductive tract improves assisted reproduction outcomes in pig”, publish by the Journal Molecular human reproduction

The research has been carried out with the participation of the NANBIOSIS  Assisted Reproduction Lab that has  a 120 m2 laboratory, small animal surgery, clinical analysis support, etc. and it is featured with two intracitoplasmatic micromanipulation equipment of the latest generation with IMSI, Laser and Oosight system, embryo biopsy systems, vision systems of the mitotic spindle, with flow cabinets with stereo-microscopes and heated plates, incubators with different gasses systems, equipment and cryopreservation freeze gamete and embryo, among others

STUDY QUESTION:

Is O2 tension in the pig oviduct and uterus affected by the estrous cycle stage and the animal’s age, and can the outcome of in vitro embryo development be improved by mimicking these physiological values?

SUMMARY ANSWER:

O2 tension within the pig reproductive organs is affected by the animal’s age, and values close to those measured in vivo have a positive impact on embryo development and quality when used during IVF and embryo culture (EC).

Article of reference: doi: 10.1093/molehr/gay008

• Read More

JUMISC awarded with the Prize to the Best Research Practice

Last Friday, May 5, JUMISC was awarded in the 1st edition of Extremadura Health Prices, event organised by Sanitaria 2000, text-editor of the Redacción Médica, the most famous and specialised newspaper in its sector.

The contribution of the Extremadura Health Service and the regional health sector were awarded between the 56 nominations included in 14 categories. JUMISC obtained the award of “Best Research Practice”.

The event was held in the convent of San Juan de Dios, in Olivenza-Badajoz, and gathered the JUMISC’s Scientific Director, Mr. Sánchez Margallo (on behalf of the institution),  together with other authorities and health managers.

A prestigious jury decided about winners in accordance to the following classification: The best public hospital, the best hospital service, the best physician, the best primary healthcare, the best health administration, the best research practice, the best private health institution, the best nursery practice, the best social responsibility for health, the best scientific society, the best technological contribution, the best association of patients and the best chemistry practice.

• Read More

10th Anniversary of the New Minimally Invasive Surgery Centre (JUMISC)

Next Friday, 21st April, we celebrate the 10th Anniversary of the new JUMISC, betting on training and on research and development activities. 

In its ten years of background we emphasize the following figures:

  • 500 trained physicians,
  • 160 training activities per year
  • More than 100 R&D projects with 7.930.800 € funding
  • 17 patents,
  • The creation of a spin-off,
  • The development of 25 apps,
  • More than 623 scientific collaborators,
  • 500 visits received from more than 500 institutions.

10 years full of training courses and European R&D projects. We are so proud for  the promotion and creation of the  Clúster Sociosanitario of Extremadura (Health Cluster), for obtaining the Good Laboratory Practice to  carry out preclinical trials, for launching a Program of training on Assisted Reproduction, for creating a 3D Department to develop apps, for being included as ICTS in the Spanish Map of Singular Facilities and in the CIBER-CV (Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares).

Jesus Usón Minimally Invasive Surgery Centre (JUMISC), one of NANBIOSIS partners together with CIBER-BBN, is a multidisciplinary institution devoted to research and innovation in health sciences.

Further info about our achievement in:

http://10aniversario.ccmijesususon.com/

• Read More

JUMISC works in a R&D project: Stem cell therapy for cartilage repair

The Jesús Usón Minimally Invasive Surgery Centre (JUMISC) works in a R&D project, that aims to find a biomaterial that will help injured cartilage to repair.

The targets of the project are to design a biomaterial that could be implanted in the human body and to apply it in the osteoarticular pathology treatment. The main goal is that people who suffer from osteoarthritis, a pathology that damages the cartilage joint, get better through a minimally invasive surgery procedure.

The consecutive phases of the project will be the development of the biomaterial, tests in vitro and the preclinical trials, as testing in pig animal model.

After finishing these phases, vet professionals will monitore them, through imaging and surgery techniques, using MRI scan and arthroscopy, to study the evolution of the injuries.

At the end of the R&D project, those injured joints where the biomaterial was implanted, will be analyzed through microscopy techniques, and vet professionals will determine if the cartilage has improved.

JUMISC and the partners of the project (enterprises, hospitals and others) are focused on testing that the treatment is safe and effective, and from this premise we will be ready to start clinical trials in hospitals, in order to demonstrate the effectiveness of the biomaterial in patients.

JUMISC- Arthroscopy -Stem cell therapy for cartilage repair
• Read More